TG Therapeutics (TGTX) and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI

Go back to TG Therapeutics (TGTX) and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI
TG THERAP (NASDAQ: TGTX) Delayed: 54.40 --0 (-0%)
Previous Close $54.40    52 Week High $14.87 
Open $54.40    52 Week Low $4.90 
Day High $54.40    P/E N/A 
Day Low $54.40    EPS $-0.67 
Volume 15,457